FIGURE

Fig. 3.

ID
ZDB-FIG-200509-37
Publication
Veerman et al., 2019 - Genetic variation in GNB5 causes bradycardia by augmenting the cholinergic response via increased acetylcholine-activated potassium current (IK,ACh)
Other Figures
All Figure Page
Back to All Figure Page
Fig. 3.

CCh induces more pronounced effects in S81Lhomo compared to WT and S81Lhet RA-treated hiPSC-CMs. (A) Representative spontaneous APs at baseline (left) and upon 10 µmol l−1 CCh (right) in WT, S81Lhet and S81Lhomo RA-treated hiPSC-CMs. The slanted arrows near the APs in the presence of CCh indicate the last AP before cessation of spontaneous activity. (B) Average frequencies before and during application of CCh. CCh drastically reduces the spontaneous AP frequency of S81Lhomo hiPSC-CMs. WT, n=10; S81Lhet, n=9; S81Lhomo, n=14. **P<0.01 (two-way repeated measures ANOVA and post-hoc Bonferroni corrected pairwise comparison). (C) Proportion of WT, S81Lhet and S81Lhomo hiPSC-CMs that became quiescent upon application of CCh. WT, n=10; S81Lhet, n=9; S81Lhomo, n=14. **P<0.01 (chi-square test, followed by Bonferroni corrected pairwise comparisons). (D) Representative APs (1 Hz overdrive stimulation) before and after the application of CCh. (E) Average maximal diastolic potential (MDP) at baseline and upon CCh in WT, S81Lhet and S81Lhomo RA-treated hiPSC-CMs (1 Hz overdrive stimulation). WT, n=17; S81Lhet, n=10; S81Lhomo, n=13. Effect of CCh on MDP is significantly more pronounced in S81Lhomo hiPSC-CMs (P<0.05 interaction effect CCh×genotype; two-way ANOVA).

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Dis. Model. Mech.